Lista de obras -

A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors

artículo científico publicado en 2017

A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity

artículo científico publicado en 2014

A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.

artículo científico publicado en 2011

A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.

artículo científico publicado en 2015

Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.

artículo científico publicado en 2014

Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma Immunotherapy.

artículo científico publicado en 2016

Cancer vaccines in phase II/III clinical trials: state of the art and future perspectives

artículo científico publicado en 2011

Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial

artículo científico publicado en 2019

Detection of HIV-1 matrix protein p17 quasispecies variants in plasma of chronic HIV-1-infected patients by ultra-deep pyrosequencing

artículo científico publicado en 2014

Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay

artículo científico publicado en 2015

Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders

artículo científico publicado en 2012

F.110. Recombinant Vk3-20 Protein As “Universal” Idiotypic Vaccine for HCV-Associated Lymphoproliferations

Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells

artículo científico publicado en 2017

High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance.

artículo científico publicado en 2007

IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas.

artículo científico publicado en 2012

Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders

artículo científico publicado en 2010

In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma

artículo científico publicado en 2017

Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas.

artículo científico

Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer

artículo científico publicado en 2017

Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.

artículo científico publicado en 2017

Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cells

article

Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets

artículo científico publicado en 2012

Retinoids as critical modulators of immune functions: new therapeutic perspectives for old compounds.

artículo científico publicado en 2009

Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer

artículo científico publicado en 2010

Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicity

artículo científico publicado en 2007

Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth

artículo científico publicado en 2014

Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy.

artículo científico publicado en 2008

Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas.

artículo científico publicado en 2013

The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders

artículo científico publicado en 2010

Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopes

artículo científico publicado en 2009

Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal- from head & neck cancer and asymptomatic EBV-infections

artículo científico publicado en 2018

Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis

artículo científico publicado en 2012

Lista de obras de

A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors

A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity

A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.

A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.

Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.

Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma Immunotherapy.

Cancer vaccines in phase II/III clinical trials: state of the art and future perspectives

Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial

Detection of HIV-1 matrix protein p17 quasispecies variants in plasma of chronic HIV-1-infected patients by ultra-deep pyrosequencing

Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay

Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders

F.110. Recombinant Vk3-20 Protein As “Universal” Idiotypic Vaccine for HCV-Associated Lymphoproliferations

Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells

High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance.

IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas.

Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders

In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma

Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas.

Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer

Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.

Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cells

Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets

Retinoids as critical modulators of immune functions: new therapeutic perspectives for old compounds.

Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer

Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicity

Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth

Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy.

Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas.

The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders

Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopes

Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal- from head & neck cancer and asymptomatic EBV-infections

Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis